Top Markets
Coin of the day
Stella Pharma Corporation Stella Pharma Corporation

Stella Pharma Corporation

4888
株式のランク #22897
Stella Pharma Corporation is a pharmaceutical company that handles the complete... Stella Pharma Corporation is a pharmaceutical company that handles the complete process of drug development, from research and manufacturing to distribution. A core area of its specialization is in therapeutic agents for boron neutron capture therapy (BNCT). Their product lineup includes SPM-011, a boron-containing drug designed for BNCT, which is utilized in the treatment of head and neck cancer, recurrent malignant glioma, meningioma, malignant melanoma, and angiosarcoma. Founded in 2007, Stella Pharma Corporation maintains its headquarters in Osaka, Japan.
株価
$2.26
最終同期: 2026-08-21
時価総額
$81.55M
変化(1日)
-0.86%
変化(1年)
-18.45%
JP
取引 Stella Pharma Corporation (4888)

カテゴリー

Stella Pharma Corporation(4888)のP/B比率
2026 時点のP/B比率 TTM: 0
Stella Pharma Corporation の最新の財務報告および株価によると、現在のP/B比率(TTM)は 0 です。2026 年末時点でのP/B比率は 0 でした。
Stella Pharma Corporation の P/B 比率の履歴(2026 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH